Interstitial Lung Disease Questionnaire

Questionnaire Study for Patients With Interstitial Lung Disease

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01711151

Enrollment

304

Registered

2012-10-22

Start date

2012-11-30

Completion date

2013-11-30

Last updated

2012-10-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Interstitial Lung Disease

Keywords

ILD

Brief summary

1. To evaluate the health status of patients with Interstitial Lung Disease (ILD), and how this varies between subgroups of ILD. 2. To investigate the prevalence of symptoms, anxiety, depression, and sleep-disordered breathing within ILD patient population. 3. To assess the economic impact of ILD. 4. To understand how self-aware ILD patients are regarding their treatment/management. 5. To compare the demographic details, including smoking status and occupational history, of patients with interstitial lung disease

Detailed description

Primary endpoint • Health status in the target populations, as determined by the K-BILD questionnaire. Secondary endpoints - * Severity of dyspnoea suffered by patients * Prevalence of anxiety and depression * Prevalence of sleep-disordered breathing symptoms * Degree of self-awareness displayed by patients * The costs associated with ILD from a patient and healthcare perspective. * Demographic details

Interventions

None listed

Study design

Observational model

CASE_CONTROL

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* Male or female * Age greater than 18 years of age * Any smoking status * Diagnosis of Interstitial Lung Disease as defined below * Full pulmonary lung function tests and routine immunological tests undertaken within 6 months of entry into study

Exclusion criteria

• Unable to give consent to take part

Design outcomes

Primary

Measure	Time frame	Description
Difference in the Mean K-BILD score between the 4 groups	Baseline	HRQL

Secondary

Measure	Time frame
Prevalence of anxiety and depression	Baseline
Prevalence of sleep-disordered breathing symptoms	Baseline
Severity of dyspnoea suffered by patients	Baseline
The costs associated with ILD from a patient and healthcare perspective	Baseline
Demographic details	Baseline
Degree of self-awareness displayed by patients	Baseline

Countries

United Kingdom

Contacts

Primary ContactAndrew M Wilson, MRCP, MD

a.m.wilson@uea.ac.uk00441603591257

Backup ContactChristopher Atkins, MBBS, MRCP

christopher.atkins@nnuh.nhs.uk00441603286286

Outcome results